Lexaria Bioscience Announces That It Has Received Partial 12-Week Body Weight Results From The Recently Completed Animal Study WEIGHT-A24-1

Benzinga · Oct 22 21:28

DehydraTECH-liraglutide and select DehydraTECH-CBD formulations were the top performing weight loss groups

Accelerated rates of weight loss were experienced during the final 4 weeks of the study in all DehydraTECH groups

KELOWNA, BC / ACCESSWIRE / October 22, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX) & (NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces that it has received partial 12-week (final) body weight results from the recently completed animal study WEIGHT-A24-1 (the "Study").

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

Lexaria Bioscience Announces That It Has Received Partial 12-Week Body Weight Results From The Recently Completed Animal Study WEIGHT-A24-1

Risk Disclaimer